Echosens
Amy Conner, MPH has an extensive work experience in the field of market access and reimbursement. Amy currently holds the position of Director, Market Access and HEOR at Echosens. Previously, they worked as the Director, Payer Contracting and Relations at Sera Prognostics from 2021 to 2022. Prior to that, they served as the Senior Director, Market Access at Fractyl from 2019 to 2021, and as the Senior Director Market Access at Alcresta Therapeutics from 2016 to 2018. Amy has also held important roles such as Director, Pricing and Market Access at ConforMIS, Inc. from 2014 to 2016, Principal Consultant-Market Access at GfK Bridgehead from 2010 to 2013, and Director of Reimbursement at Baxano (formerly TranS1) from 2008 to 2010. Additionally, they were the Senior Manager, Reimbursement at QIAGEN from 2003 to 2008, an Analyst at The Frankel Group from 2002 to 2003, and an Associate at Boston Healthcare Associates from 2001 to 2002. Amy has extensive knowledge and expertise in developing and implementing market access strategies, conducting reimbursement campaigns, and managing payer contracting and relations.
Amy Conner, MPH, completed their Bachelor of Arts degree from Boston University in 1997. Amy then pursued further education at the Boston University School of Public Health and obtained a Master's degree in Public Health in 2001.
This person is not in any offices
Echosens
1 followers
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 4,200+ peer-reviewed publications and 180+ international guidelines recommendations. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide. We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH. As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.